Physician profile
Matthew Dunham
NPI 1891841490
$4,957.63
in general payments reported to CMS, 2019-2025
31 companies · $57.07 in 2025
The $57.07 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,678 · 2020: $689 · 2021: $279 · 2022: $167 · 2023: $74.58 · 2024: $13.24 · 2025: $57.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $144.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,000.00 | 2019 | |
| Amgen INC. | $235.43 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $194.26 | 2019 | |
| Abbvie INC. | $162.87 | 2019-2020 | |
| Allergan, INC. | $152.15 | 2020 | |
| Medtronic USA, INC. | $143.63 | 2020 | |
| Alexion Pharmaceuticals, INC. | $140.73 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.93 | 2019-2025 | |
| Baxter Healthcare | $105.02 | 2020-2021 | |
| Coloplast Corp | $104.08 | 2022-2023 | Altis |
| Acelrx Pharmaceuticals, INC. | $101.33 | 2021 | |
| Genentech USA, INC. | $91.61 | 2019 | |
| Pfizer INC. | $51.64 | 2019-2020 | |
| Therapeuticsmd, INC. | $45.80 | 2019 | |
| Boston Scientific Corporation | $38.57 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $25.97 | 2022 | |
| Hologic Sales and Service, LLC | $22.21 | 2021 | |
| Covidien Lp | $22.03 | 2019 | |
| Teleflex LLC | $21.28 | 2025 | Quikclot |
| Urovant Sciences INC | $19.11 | 2022 | |
| Exeltis, USA INC. | $18.98 | 2023 | Slynd |
| Solventum Corporation | $18.71 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Coopersurgical, INC. | $17.74 | 2019 | |
| Merck Sharp & Dohme LLC | $17.34 | 2020 | |
| Axonics, INC. | $14.66 | 2022 | |
| Davol INC. | $13.24 | 2024 | Arista Ah Flexitip |
| Caldera Medical, INC | $12.74 | 2021 | |
| Astellas Pharma US INC | $11.75 | 2022 | |
| Sanofi Pasteur INC. | $11.65 | 2019 | |
| Vertical Pharmaceuticals, LLC | $11.09 | 2019 | |
| Ethicon US, LLC | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Dunham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.